Cresset Asset Management’s Elanco Animal Health ELAN Stock Holding History

Cresset Asset Management’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$256K	Sell	10,391 -6,913	-40%	-$160K	﹤0.01%	1462
2026 Q1	$414K	Buy	17,304 +7,476	+76%	+$183K	﹤0.01%	1143
2025 Q4	$222K	Sell	9,828 -1,494	-13%	-$32.5K	﹤0.01%	1440
2025 Q3	$228K	Buy	+11,322	New	+$190K	﹤0.01%	1366
2025 Q2	–	Sell	-10,051	Closed	-$106K	–	1536
2025 Q1	$106K	Sell	10,051 -5,915	-37%	-$66.9K	﹤0.01%	1616
2024 Q4	$193K	Sell	15,966 -76,941	-83%	-$1.01M	﹤0.01%	1573
2024 Q3	$1.36M	Buy	92,907 +29,448	+46%	+$410K	0.01%	1002
2024 Q2	$916K	Sell	63,459 -135	-0.2%	-$2.16K	﹤0.01%	1118
2024 Q1	$1.04M	Sell	63,594 -6,884	-10%	-$108K	0.01%	959
2023 Q4	$1.05M	Buy	70,478 +21,678	+44%	+$246K	0.01%	879
2023 Q3	$549K	Sell	48,800 -1,875	-4%	-$21.8K	﹤0.01%	1130
2023 Q2	$510K	Buy	+50,675	New	+$470K	﹤0.01%	1273
2019 Q2	–	Sell	-9	Closed	–	–	820
2019 Q1	$0	Buy	+9	New	+$277	﹤0.01%	2014

Other funds holding ELAN

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Cresset Asset Management's ELAN Position: Q2 2026 in Review

Cresset Asset Management reduced its Elanco Animal Health (ELAN) stake by 40% in Q2 2026, selling an estimated $160K and leaving 10,391 shares worth $256K. The position accounts for ﹤0.01% of the portfolio, ranked #1462.

Cresset Asset Management first reported a position in ELAN in Q1 2019 and has held it in 13 quarters since. The position peaked at $1.36M in Q3 2024. 520 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

Cresset Asset Management held 10,391 shares of Elanco Animal Health worth $256K as of Q2 2026.
Cresset Asset Management sold 6,913 Elanco Animal Health shares in Q2 2026, an estimated $160K.
Elanco Animal Health made up ﹤0.01% of Cresset Asset Management's portfolio in Q2 2026, its #1462 holding.
Cresset Asset Management first reported a position in Elanco Animal Health in Q1 2019 and has held it in 13 quarters since.
Cresset Asset Management's Elanco Animal Health position peaked at $1.36M in Q3 2024.
520 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Cresset Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.